首页 › 基金 › Avidity Partners Management LP › NVCT

Avidity Partners Management LP 对 NVCT 的持仓历史

NUVECTIS PHARMA INC COM · 医疗保健

Avidity Partners Management LP 在 Q2 2026 的 13F 申报中披露持有 NVCT(NUVECTIS PHARMA INC COM)200,000 股,市值约 US$3.7M,约占其申报组合的 0.59%,在其申报持仓中市值排名第 22 位。 Avidity Partners Management LP 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)200.00K 股
申报持仓市值$3.68M
组合权重0.59%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Avidity Partners Management LP 对 NVCT 的持仓演变

Avidity Partners Management LP 于 Q2 2026 首次披露 NVCT 持仓:200,000 股(约 US$3.7M)。

逐季持仓明细

季度股数金额变化
Q2 2026 200.00K $3.68M 新进

关于 NVCT 与 13F 数据

NVCT(NUVECTIS PHARMA INC COM)属于医疗保健行业。我们追踪的基金中还有 61 只申报持有 NVCT,申报仓位最大的包括:TANG CAPITAL MANAGEMENT LLC (US$28.5M), Soleus Capital Management, L.P. (US$18.4M), IRIDIAN ASSET MANAGEMENT LLC/CT (US$14.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 NVCT 的基金

查看 NVCT 的全部基金持有人 →

常见问题

How long has Avidity Partners Management LP held NVCT?

Avidity Partners Management LP has disclosed NVCT holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Avidity Partners Management LP's current position in NVCT?

As of Q2 2026, Avidity Partners Management LP holds 200.00K shares of NVCT (NUVECTIS PHARMA INC COM), valued at $3.68M, representing 0.59% of its reported portfolio and ranking #22.

Has Avidity Partners Management LP been buying or selling NVCT?

In the latest 13F filing (Q2 2026), Avidity Partners Management LP newly opened its position in NVCT.

Which other funds hold NVCT?

Other major institutional holders of NVCT include TANG CAPITAL MANAGEMENT LLC, Soleus Capital Management, L.P., IRIDIAN ASSET MANAGEMENT LLC/CT, among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.